文献速递乳腺技术与安全MRPETCT

MRI与俯卧位FDG PET/CT融合可改善乳腺癌患者原发肿瘤分期

MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer.
PubMed 文献 · Eur Radiol · 2016-12-21

本回顾性研究纳入45例女性49个病理证实的乳腺癌,评估MRI与俯卧位FDG PET/CT融合对原发肿瘤分期的诊断准确性。病灶分析显示融合影像的敏感度97%、特异度94%、AUC 0.983,优于单独MRI(AUC 0.953)和单独PET(AUC 0.850),且提高了MRI的特异度。

要点

  • MRI融合俯卧位FDG PET/CT病灶分析敏感度97%、特异度94%、AUC 0.983。
  • 融合影像特异度94%高于单独MRI的80%和单独PET的71%。
  • 融合影像AUC 0.983高于单独MRI的0.953和单独PET的0.850(p < 0.01)。

核心结论

  • MRI与FDG-PET融合在乳腺癌原发肿瘤分期中比FDG-PET更准确,并提高了MRI的特异度。

研究设计与样本

  • 回顾性研究,纳入45例女性49个病理证实的乳腺癌;MRI与俯卧位PET-CT采用相同专用乳腺线圈,PET-CT采用飞行时间和点扩散函数重建;由放射科医师和核医学科医师评估,融合图像以共识方式评价;最终诊断基于病理(90个病灶)或随访≥24个月(17个病灶)。

诊断标准与关键数值

  • 共评估72个恶性、35个良性病灶,中位大小1.8 cm(范围0.3-8.4 cm);31例局灶性、9例多灶性、9例多中心性;病灶分析敏感度、特异度、阳性预测值、阴性预测值:MRI为97%、80%、91%、93%,俯卧位PET为96%、71%、87%、89%,MRI融合PET为97%、94%、97%、94%;AUC分别为0.953、0.850、0.983(p < 0.01)。

临床应用与阅片要点

  • 原文结论指出MRI融合FDG-PET在乳腺癌原发肿瘤分期中比FDG-PET更准确并提高MRI特异度;原文要点指出FDG PET-CT可能提高MRI在乳腺癌分期中的特异度,融合PET-MRI的临床作用尚未确立。

局限性

  • 原文要点指出融合PET-MRI的临床作用尚未确立。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Our aim was to evaluate the diagnostic accuracy of magnetic resonance imaging (MRI) fused with prone 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) in primary tumour staging of patients with breast cancer.

METHODS: This retrospective study evaluated 45 women with 49 pathologically proven breast carcinomas. MRI and prone PET-CT scans with time-of-flight and point-spread-function reconstruction were performed with the same dedicated breast coil. The studies were assessed by a radiologist and a nuclear medicine physician, and evaluation of fused images was made by consensus. The final diagnosis was based on pathology (90 lesions) or follow-up ≥ 24 months (17 lesions).

RESULTS: The study assessed 72 malignant and 35 benign lesions with a median size of 1.8 cm (range 0.3-8.4 cm): 31 focal, nine multifocal and nine multicentric cases. In lesion-by-lesion analysis, sensitivity, specificity, positive and negative predictive values were 97%, 80%, 91% and 93% for MRI, 96%, 71%, 87%, and 89% for prone PET, and 97%. 94%, 97% and 94% for MRI fused with PET. Areas under the curve (AUC) were 0.953, 0.850, and 0.983, respectively (p < 0.01).

CONCLUSIONS: MRI fused with FDG-PET is more accurate than FDG-PET in primary tumour staging of breast cancer patients and increases the specificity of MRI.

KEY POINTS: • FDG PET-CT may improve the specificity of MRI in breast cancer staging. • MRI fused with prone 2-[fluorine-18]-fluoro-2-deoxy-D-glucose PET-CT has better overall diagnostic performance than MRI. • The clinical role of fused PET-MRI has not yet been established.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Garcia-Velloso MJ, Ribelles MJ, Rodriguez M, et al. MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer. Eur Radiol. 2016. PMID: 28004161. doi:10.1007/s00330-016-4685-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。